Now showing items 1-1 of 1

    • Faster access to new drugs doesn’t always mean better treatment 

      Ghinea, N; Lipworth, W (The Conversation, 2017-03-15)
      US President Donald Trump recently chose an adviser to a large pharmaceutical company to lead the country’s drug regulation agency. Scott Gottlieb – who reportedly sits on the boards of several small drug companies and ...